ROBERT PEDEN EYE SURGERY LIMITED

Active Edinburgh

Specialists medical practice activities

1 employees website.com
Specialists medical practice activities
R

ROBERT PEDEN EYE SURGERY LIMITED

Specialists medical practice activities

Founded 22 Apr 2022 Active Edinburgh, Scotland 1 employees website.com
Specialists medical practice activities
Accounts Submitted 17 Feb 2026 Next due 30 Apr 2026 28 days overdue
Confirmation Submitted 30 Apr 2026 Next due 5 May 2027 11 months remaining
Net assets £101K £41K 2025 year on year
Total assets £136K £31K 2025 year on year
Total Liabilities £34K £10K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

6 St. Colme Street Edinburgh EH3 6AD Scotland

Full company profile for ROBERT PEDEN EYE SURGERY LIMITED (SC730317), an active company based in Edinburgh, Scotland. Incorporated 22 Apr 2022. Specialists medical practice activities. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 May → 30 Apr 2025
Type micro-entity
Next accounts 30 Apr 2025
Due by 30 Apr 2026 1 month overdue

Net Assets, Total Assets & Total Liabilities (2023–2025)

Cash in Bank

N/A

Net Assets

£101.36k

Increased by £41.13k (+68%)

Total Liabilities

£34.45k

Decreased by £9.71k (-22%)

Turnover

N/A

Employees

1

Debt Ratio

25%

Decreased by 17 (-40%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
30 Apr Year End
2024
30 Apr Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active
Status
Peden, Robert George, DrDirectorBritishUnited Kingdom4122 Apr 2022Active

Shareholders

Shareholders (3)

Robert Peden
98.0%
Sarah Griffin
1.0%

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Robert George Peden

British

Active
Notified 22 Apr 2022
Residence United Kingdom
DOB June 1984
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Dr Robert George Peden

British

Active
Notified 22 Apr 2022
Residence United Kingdom
DOB June 1984
Nature of Control
  • Ownership Of Shares 75 To 100 Percent
  • Voting Rights 75 To 100 Percent
  • Right To Appoint And Remove Directors

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
30 Apr 2026Confirmation StatementConfirmation statement made on 21 Apr 2026 with updates
30 Apr 2026OfficersChange to director Dr Robert George Peden on 30 Apr 2026
25 Mar 2026ResolutionResolutions
24 Mar 2026CapitalAllotment of shares (GBP 101) on 22 Mar 2026
24 Mar 2026IncorporationMemorandum Articles
30 Apr 2026 Confirmation Statement

Confirmation statement made on 21 Apr 2026 with updates

30 Apr 2026 Officers

Change to director Dr Robert George Peden on 30 Apr 2026

25 Mar 2026 Resolution

Resolutions

24 Mar 2026 Capital

Allotment of shares (GBP 101) on 22 Mar 2026

24 Mar 2026 Incorporation

Memorandum Articles

Recent Activity

Latest Activity

Confirmation statement made on 21 Apr 2026 with updates

3 weeks ago on 30 Apr 2026

Change to director Dr Robert George Peden on 30 Apr 2026

3 weeks ago on 30 Apr 2026

Resolutions

2 months ago on 25 Mar 2026

Allotment of shares (GBP 101) on 22 Mar 2026

2 months ago on 24 Mar 2026

Memorandum Articles

2 months ago on 24 Mar 2026